What is the price-to-earnings ratio of PolyPid?
The price-earnings ratio of PolyPid is currently 0.
PolyPid P/S 2024
PolyPid P/S
0
Ticker
PYPD
ISIN
IL0011326795
WKN
A2JNTB
As of Nov 16, 2024, PolyPid's P/S ratio stood at 0, a 0% change from the 0 P/S ratio recorded in the previous year.
The PolyPid P/S history
PolyPid Aktienanalyse
What does PolyPid do?
PolyPid Ltd is an innovative, emerging company in the field of biomedical technology based in Israel. The company was founded in 2008 and has since gained continuous recognition and growth. PolyPid's core business is the development and manufacturing of implantable polymer systems that contribute to wound healing. These polymer systems are specifically introduced into the affected area of the body and continuously release active substances to prevent infections and promote natural healing processes. PolyPid's business model is focused on effectively solving patients' problems. The company has developed a wide range of products and technologies that specifically target various medical applications. These include orthopedics, traumatology, urology, and gynecology. For orthopedics, PolyPid provides various products and technologies that can be used in knee and hip joint surgeries. These include antibiotic-releasing implants to prevent infections and resorbable bone fillers that allow for faster and more effective wound healing. In the field of traumatology, PolyPid manufactures polymer systems that are used in the treatment of bone fractures or other traumas. Here again, the polymer systems ensure continuous release of active substances to prevent infections and promote natural healing processes. PolyPid also offers innovative solutions for urology. Specifically, products are developed to combat urinary tract infections and promote faster wound healing after urological surgeries. For gynecology, PolyPid offers polymer systems that can be used particularly in the postoperative phase to prevent infections and achieve faster wound healing. PolyPid has earned an excellent reputation in the industry in recent years due to its consistent focus on innovation and quality. To continually improve their products, the company invests heavily in research and development and maintains close contact with medical institutions and professionals worldwide. PolyPid is an important partner in the field of biomedical technology and has already received numerous awards for its groundbreaking products and developments. Thanks to its focus on quality, reliability, and innovation, the company will continue to play a key role in the biomedical technology market. PolyPid ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding PolyPid's P/S Ratio
PolyPid's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing PolyPid's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating PolyPid's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in PolyPid’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about PolyPid stock
How has the price-earnings ratio of PolyPid changed compared to last year?
The price-to-earnings ratio of PolyPid has increased by 0% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of PolyPid high compared to other companies?
Yes, the price-to-earnings ratio of PolyPid is high compared to other companies.
How does an increase in the price-earnings ratio of PolyPid affect the company?
An increase in the price-earnings ratio of PolyPid would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of PolyPid affect the company?
A decrease in the price-earnings ratio of PolyPid would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of PolyPid?
Some factors that influence the price-earnings ratio of PolyPid are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does PolyPid pay?
Over the past 12 months, PolyPid paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, PolyPid is expected to pay a dividend of 0 USD.
What is the dividend yield of PolyPid?
The current dividend yield of PolyPid is .
When does PolyPid pay dividends?
PolyPid pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of PolyPid?
PolyPid paid dividends every year for the past 0 years.
What is the dividend of PolyPid?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is PolyPid located?
PolyPid is assigned to the '-' sector.
Wann musste ich die Aktien von PolyPid kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of PolyPid from 11/16/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/16/2024.
When did PolyPid pay the last dividend?
The last dividend was paid out on 11/16/2024.
What was the dividend of PolyPid in the year 2023?
In the year 2023, PolyPid distributed 0 USD as dividends.
In which currency does PolyPid pay out the dividend?
The dividends of PolyPid are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von PolyPid
Our stock analysis for PolyPid Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of PolyPid Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.